0001140361-16-066876.txt : 20160524
0001140361-16-066876.hdr.sgml : 20160524
20160524165857
ACCESSION NUMBER: 0001140361-16-066876
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160520
FILED AS OF DATE: 20160524
DATE AS OF CHANGE: 20160524
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Emergent BioSolutions Inc.
CENTRAL INDEX KEY: 0001367644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 141902018
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
BUSINESS PHONE: 240-631-3200
MAIL ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Abdun-Nabi Daniel
CENTRAL INDEX KEY: 0001380187
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33137
FILM NUMBER: 161672457
MAIL ADDRESS:
STREET 1: 400 PROFESSIONAL DRIVE
STREET 2: SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
4
1
doc1.xml
FORM 4
X0306
4
2016-05-20
0
0001367644
Emergent BioSolutions Inc.
EBS
0001380187
Abdun-Nabi Daniel
400 PROFESSIONAL DR, SUITE 400
GAITHERSBURG
MD
20879
1
1
0
0
President & CEO
Common Stock
2016-05-20
4
S
0
8701
42.00
D
179665
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Abdun-Nabi.
Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.82 to $42.22, inclusive.
/s/ Eric Burt, Attorney-in-fact
2016-05-24